Guanhao Biotech's stock performs well despite past year's pr...
Guanhao Biotech's stock performs well despite past year's profit loss and shrinking revenue. High total return shows rising investor sentiment, despite little correlation with past revenue.
Guanhao BiotechLtd (SZSE:300238) Delivers Shareholders Notable 7.1% CAGR Over 5 Years, Surging 12% in the Last Week Alone
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment